These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6470592)

  • 1. Tamoxifen in the treatment of osseous metastatic breast cancer. A case report.
    Tepmongkol P
    J Med Assoc Thai; 1984 Mar; 67(3):188-93. PubMed ID: 6470592
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer.
    Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY
    Oncol Rep; 2003; 10(1):141-4. PubMed ID: 12469160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen-induced hypercalcemia in metastatic breast cancer.
    Nemoto T; Rosner DH; Patel DJ; Wettingfeld RF; Bambrah SS; Dao TL
    N Y State J Med; 1980 Dec; 80(13):1980-2. PubMed ID: 6937756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Flare phenomenon: favorable or unfavorable?].
    Peters-Christodoulou MN; Nooy MA
    Ned Tijdschr Geneeskd; 1990 Jun; 134(24):1161-3. PubMed ID: 2366902
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progestational agents and bone metastasis in breast cancer].
    Leriche N; Bonneterre J
    Bull Cancer; 1997 Sep; 84(9):891-4. PubMed ID: 9435812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study.
    Milla-Santos A; Milla L; Portella J; Rallo L; Pons M; Rodes E; Casanovas J; Puig-Gali M
    Am J Clin Oncol; 2003 Jun; 26(3):317-22. PubMed ID: 12796608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of chemotherapy in the treatment of bone metastases of breast cancer].
    Cayla J; Auclerc C; Goldberg D; Darne C; Jacquillat C
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):651-6. PubMed ID: 6523016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review.
    Isaacs RJ; Hunter W; Clark K
    Gynecol Oncol; 2001 Mar; 80(3):405-8. PubMed ID: 11263941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
    Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
    J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen-related vasculitis.
    Baptista MZ; Prieto VG; Chon S; Hortobagyi GN; Esteva FJ
    J Clin Oncol; 2006 Jul; 24(21):3504-5. PubMed ID: 16849770
    [No Abstract]   [Full Text] [Related]  

  • 12. Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer.
    Duivenvoorden WC; Popović SV; Lhoták S; Seidlitz E; Hirte HW; Tozer RG; Singh G
    Cancer Res; 2002 Mar; 62(6):1588-91. PubMed ID: 11912125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future status of adjuvant therapy for breast cancer.
    Coleman RE
    Cancer; 2003 Feb; 97(3 Suppl):880-6. PubMed ID: 12548590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humeral metastasis in breast cancer patients: radiotherapeutic management of 21 cases.
    Ampil FL; Caldito G; Sangster GP; Ursua VA
    Breast J; 2009; 15(3):315-7. PubMed ID: 19645795
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basic Consensus on endocrinotherapy for breast cancer].
    Jiang ZF; Xu BH; Song ST
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):238-9. PubMed ID: 16875616
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
    Satoh Y; Une Y; Fujisawa J; Uchino J
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability.
    Mouridsen H; Sun Y; Gershanovich M; Perez-Carrion R; Becquart D; Chaudri-Ross HA; Lang R
    Oncologist; 2004; 9(5):489-96. PubMed ID: 15477633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
    Sakurai T; Tatematsu H; Yamataka K; Yamamoto T; Kawahara H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2029-34. PubMed ID: 11791380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial.
    Westerberg H
    Cancer Treat Rep; 1980 Jan; 64(1):117-21. PubMed ID: 6991101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.